JP2012509940A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012509940A5 JP2012509940A5 JP2011538682A JP2011538682A JP2012509940A5 JP 2012509940 A5 JP2012509940 A5 JP 2012509940A5 JP 2011538682 A JP2011538682 A JP 2011538682A JP 2011538682 A JP2011538682 A JP 2011538682A JP 2012509940 A5 JP2012509940 A5 JP 2012509940A5
- Authority
- JP
- Japan
- Prior art keywords
- pyrrol
- octahydrocyclopenta
- trifluoromethyl
- methyl
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- -1 nitro, oxo, phenyl Chemical group 0.000 claims 217
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 213
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims 140
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 111
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 95
- 229910052739 hydrogen Inorganic materials 0.000 claims 61
- 239000001257 hydrogen Substances 0.000 claims 61
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 claims 49
- 125000003118 aryl group Chemical group 0.000 claims 41
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 40
- 125000000753 cycloalkyl group Chemical group 0.000 claims 34
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims 29
- 125000001072 heteroaryl group Chemical group 0.000 claims 20
- 150000002431 hydrogen Chemical group 0.000 claims 20
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 claims 19
- 150000001875 compounds Chemical class 0.000 claims 19
- 150000003839 salts Chemical class 0.000 claims 19
- 125000004432 carbon atom Chemical group C* 0.000 claims 12
- 125000000623 heterocyclic group Chemical group 0.000 claims 11
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 10
- 229910052736 halogen Inorganic materials 0.000 claims 9
- 150000002367 halogens Chemical class 0.000 claims 9
- 125000002911 monocyclic heterocycle group Chemical group 0.000 claims 9
- 125000005842 heteroatom Chemical group 0.000 claims 8
- 125000000217 alkyl group Chemical group 0.000 claims 7
- 229910052760 oxygen Inorganic materials 0.000 claims 7
- IPWFJLQDVFKJDU-UHFFFAOYSA-N pentanamide Chemical compound CCCCC(N)=O IPWFJLQDVFKJDU-UHFFFAOYSA-N 0.000 claims 7
- 125000001424 substituent group Chemical group 0.000 claims 7
- 229910052717 sulfur Inorganic materials 0.000 claims 7
- 229960004295 valine Drugs 0.000 claims 7
- NEURYOYRKPFLKH-UHFFFAOYSA-N 2-chloro-1-isocyanato-4-(trifluoromethyl)benzene Chemical group FC(F)(F)C1=CC=C(N=C=O)C(Cl)=C1 NEURYOYRKPFLKH-UHFFFAOYSA-N 0.000 claims 6
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims 6
- 125000004176 4-fluorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1F)C([H])([H])* 0.000 claims 6
- 150000001408 amides Chemical class 0.000 claims 6
- 125000000392 cycloalkenyl group Chemical group 0.000 claims 6
- 125000002950 monocyclic group Chemical group 0.000 claims 6
- 229910052757 nitrogen Inorganic materials 0.000 claims 6
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 6
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 6
- 208000002193 Pain Diseases 0.000 claims 5
- 125000002618 bicyclic heterocycle group Chemical group 0.000 claims 5
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 5
- 125000004122 cyclic group Chemical group 0.000 claims 5
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- GPYTYOMSQHBYTK-LURJTMIESA-N (2s)-2-azaniumyl-2,3-dimethylbutanoate Chemical compound CC(C)[C@](C)([NH3+])C([O-])=O GPYTYOMSQHBYTK-LURJTMIESA-N 0.000 claims 4
- 125000006374 C2-C10 alkenyl group Chemical group 0.000 claims 4
- 125000005865 C2-C10alkynyl group Chemical group 0.000 claims 4
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 claims 4
- 125000002619 bicyclic group Chemical group 0.000 claims 4
- 229910052799 carbon Inorganic materials 0.000 claims 4
- 125000004093 cyano group Chemical group *C#N 0.000 claims 4
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 4
- 125000003548 sec-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 4
- QCIGLPLDNRDLQQ-UHFFFAOYSA-N butan-2-ylcarbamic acid Chemical compound CCC(C)NC(O)=O QCIGLPLDNRDLQQ-UHFFFAOYSA-N 0.000 claims 3
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 claims 3
- HZMVPSHLMIQQNX-UHFFFAOYSA-N pentan-2-yl carbamate Chemical compound CCCC(C)OC(N)=O HZMVPSHLMIQQNX-UHFFFAOYSA-N 0.000 claims 3
- NPDWHDXPQPMHJR-UHFFFAOYSA-N pentan-2-ylcarbamic acid Chemical compound CCCC(C)NC(O)=O NPDWHDXPQPMHJR-UHFFFAOYSA-N 0.000 claims 3
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 3
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 2
- WAUGGYPDCQZJKK-UHFFFAOYSA-N 1h-pyrrol-3-amine Chemical compound NC=1C=CNC=1 WAUGGYPDCQZJKK-UHFFFAOYSA-N 0.000 claims 2
- 125000002981 3-(trifluoromethyl)benzoyl group Chemical group FC(C=1C=C(C(=O)*)C=CC1)(F)F 0.000 claims 2
- 125000004180 3-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(F)=C1[H] 0.000 claims 2
- 208000020925 Bipolar disease Diseases 0.000 claims 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 2
- 208000019695 Migraine disease Diseases 0.000 claims 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 claims 2
- 125000004429 atom Chemical group 0.000 claims 2
- DNSISZSEWVHGLH-UHFFFAOYSA-N butanamide Chemical compound CCCC(N)=O DNSISZSEWVHGLH-UHFFFAOYSA-N 0.000 claims 2
- 208000015114 central nervous system disease Diseases 0.000 claims 2
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 208000035475 disorder Diseases 0.000 claims 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 2
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 2
- 206010027599 migraine Diseases 0.000 claims 2
- YNTOKMNHRPSGFU-UHFFFAOYSA-N n-Propyl carbamate Chemical compound CCCOC(N)=O YNTOKMNHRPSGFU-UHFFFAOYSA-N 0.000 claims 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 2
- 125000004043 oxo group Chemical group O=* 0.000 claims 2
- QLNJFJADRCOGBJ-UHFFFAOYSA-N propionamide Chemical compound CCC(N)=O QLNJFJADRCOGBJ-UHFFFAOYSA-N 0.000 claims 2
- 125000004528 pyrimidin-5-yl group Chemical group N1=CN=CC(=C1)* 0.000 claims 2
- 125000000169 tricyclic heterocycle group Chemical group 0.000 claims 2
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims 2
- VGEIIVMUMFPNKY-SAJDGTNDSA-N (2S)-N-[(3aR,4S,6aS)-2-[[3-(trifluoromethyl)phenyl]methyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-4-yl]-2-amino-4-methyl-2-methylsulfonylpentanamide Chemical compound CS(=O)(=O)[C@@](N)(CC(C)C)C(=O)N[C@H]1CC[C@@H]2CN(C[C@@H]21)CC1=CC(=CC=C1)C(F)(F)F VGEIIVMUMFPNKY-SAJDGTNDSA-N 0.000 claims 1
- VGEIIVMUMFPNKY-SFFNPBHPSA-N (2S)-N-[(3aS,4R,6aR)-2-[[3-(trifluoromethyl)phenyl]methyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-4-yl]-2-amino-4-methyl-2-methylsulfonylpentanamide Chemical compound CS(=O)(=O)[C@@](N)(CC(C)C)C(=O)N[C@@H]1CC[C@H]2CN(C[C@H]21)CC1=CC(=CC=C1)C(F)(F)F VGEIIVMUMFPNKY-SFFNPBHPSA-N 0.000 claims 1
- AFYSEMLDHWBGBG-LUKWVAJMSA-N (2r)-n-[(3ar,4s,6as)-2-benzyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-2-phenylbutanamide Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)NC(=O)[C@H](CC)C=2C=CC=CC=2)N1CC1=CC=CC=C1 AFYSEMLDHWBGBG-LUKWVAJMSA-N 0.000 claims 1
- ZIIGNHNCZKJHGP-GFRNBQLOSA-N (2r)-n-[(3ar,4s,6as)-2-benzyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-2-phenylpropanamide Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)NC(=O)[C@H](C)C=2C=CC=CC=2)N1CC1=CC=CC=C1 ZIIGNHNCZKJHGP-GFRNBQLOSA-N 0.000 claims 1
- ZHCVAQPWDAYWNI-OLKYXYMISA-N (2r)-n-[(3as,4r,6ar)-2-benzyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-3,3-dimethyl-2-phenylbutanamide Chemical compound C([C@@H]1CC[C@H]([C@@H]1C1)NC(=O)[C@H](C(C)(C)C)C=2C=CC=CC=2)N1CC1=CC=CC=C1 ZHCVAQPWDAYWNI-OLKYXYMISA-N 0.000 claims 1
- XGHGKVOKFBNHFC-QCSYZSNVSA-N (2s)-n-[(3ar,4s,6as)-2-[3-(trifluoromethyl)phenyl]sulfonyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]piperidine-2-carboxamide Chemical compound FC(F)(F)C1=CC=CC(S(=O)(=O)N2C[C@@H]3[C@@H](NC(=O)[C@H]4NCCCC4)CC[C@@H]3C2)=C1 XGHGKVOKFBNHFC-QCSYZSNVSA-N 0.000 claims 1
- VFMZAEZBXACMRF-QKDIEKDRSA-N (2s)-n-[(3ar,4s,6as)-2-benzyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-2-[4-(2-methylpropyl)phenyl]propanamide Chemical compound C1=CC(CC(C)C)=CC=C1[C@H](C)C(=O)N[C@@H]1[C@H]2CN(CC=3C=CC=CC=3)C[C@H]2CC1 VFMZAEZBXACMRF-QKDIEKDRSA-N 0.000 claims 1
- AFYSEMLDHWBGBG-LDVJMBRRSA-N (2s)-n-[(3ar,4s,6as)-2-benzyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-2-phenylbutanamide Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)NC(=O)[C@@H](CC)C=2C=CC=CC=2)N1CC1=CC=CC=C1 AFYSEMLDHWBGBG-LDVJMBRRSA-N 0.000 claims 1
- ZIIGNHNCZKJHGP-XGARDCMYSA-N (2s)-n-[(3ar,4s,6as)-2-benzyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-2-phenylpropanamide Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)NC(=O)[C@@H](C)C=2C=CC=CC=2)N1CC1=CC=CC=C1 ZIIGNHNCZKJHGP-XGARDCMYSA-N 0.000 claims 1
- JIJXKKFQLDKTJP-LIRZEXBASA-N (2s)-n-[(3as,4r,6ar)-2-(4-fluorophenyl)sulfonyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]piperidine-2-carboxamide Chemical compound C1=CC(F)=CC=C1S(=O)(=O)N1C[C@H]2[C@H](NC(=O)[C@H]3NCCCC3)CC[C@H]2C1 JIJXKKFQLDKTJP-LIRZEXBASA-N 0.000 claims 1
- WQZWOLQTLQNVGD-OTGYPNLISA-N (2s)-n-[(3as,4r,6ar)-2-[(1s)-1-phenylethyl]-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-2-phenylbutanamide Chemical compound C1([C@H](C)N2C[C@@H]3CC[C@H]([C@@H]3C2)NC(=O)[C@@H](CC)C=2C=CC=CC=2)=CC=CC=C1 WQZWOLQTLQNVGD-OTGYPNLISA-N 0.000 claims 1
- PJQNPTHRIJPDSO-AITUJVMLSA-N (2s)-n-[(3as,4r,6ar)-2-[(4-fluorophenyl)methyl]-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]piperidine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CN1C[C@H]2[C@H](NC(=O)[C@H]3NCCCC3)CC[C@H]2C1 PJQNPTHRIJPDSO-AITUJVMLSA-N 0.000 claims 1
- XGHGKVOKFBNHFC-LIRZEXBASA-N (2s)-n-[(3as,4r,6ar)-2-[3-(trifluoromethyl)phenyl]sulfonyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]piperidine-2-carboxamide Chemical compound FC(F)(F)C1=CC=CC(S(=O)(=O)N2C[C@H]3[C@H](NC(=O)[C@H]4NCCCC4)CC[C@H]3C2)=C1 XGHGKVOKFBNHFC-LIRZEXBASA-N 0.000 claims 1
- XHAOOIHWQCRONK-LIRZEXBASA-N (2s)-n-[(3as,4r,6ar)-2-[4-(trifluoromethyl)phenyl]sulfonyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]piperidine-2-carboxamide Chemical compound C1=CC(C(F)(F)F)=CC=C1S(=O)(=O)N1C[C@H]2[C@H](NC(=O)[C@H]3NCCCC3)CC[C@H]2C1 XHAOOIHWQCRONK-LIRZEXBASA-N 0.000 claims 1
- XBKSTLUJFXKPCT-AITUJVMLSA-N (2s)-n-[(3as,4r,6ar)-2-[[4-(trifluoromethyl)phenyl]methyl]-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]piperidine-2-carboxamide Chemical compound C1=CC(C(F)(F)F)=CC=C1CN1C[C@H]2[C@H](NC(=O)[C@H]3NCCCC3)CC[C@H]2C1 XBKSTLUJFXKPCT-AITUJVMLSA-N 0.000 claims 1
- AFYSEMLDHWBGBG-MYDTUXCISA-N (2s)-n-[(3as,4r,6ar)-2-benzyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-2-phenylbutanamide Chemical compound C([C@@H]1CC[C@H]([C@@H]1C1)NC(=O)[C@@H](CC)C=2C=CC=CC=2)N1CC1=CC=CC=C1 AFYSEMLDHWBGBG-MYDTUXCISA-N 0.000 claims 1
- ZIIGNHNCZKJHGP-GUGJDKNPSA-N (2s)-n-[(3as,4r,6ar)-2-benzyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-2-phenylpropanamide Chemical compound C([C@@H]1CC[C@H]([C@@H]1C1)NC(=O)[C@@H](C)C=2C=CC=CC=2)N1CC1=CC=CC=C1 ZIIGNHNCZKJHGP-GUGJDKNPSA-N 0.000 claims 1
- ZHCVAQPWDAYWNI-KEZOAJOQSA-N (2s)-n-[(3as,4r,6ar)-2-benzyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-3,3-dimethyl-2-phenylbutanamide Chemical compound C([C@@H]1CC[C@H]([C@@H]1C1)NC(=O)[C@@H](C(C)(C)C)C=2C=CC=CC=2)N1CC1=CC=CC=C1 ZHCVAQPWDAYWNI-KEZOAJOQSA-N 0.000 claims 1
- NUBHGCWUZZYQCT-AFXVXQJMSA-N (2s)-n-[(3as,4r,6ar)-2-benzyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-4-methyl-2-morpholin-4-ylpentanamide Chemical compound N1([C@@H](CC(C)C)C(=O)N[C@H]2[C@@H]3CN(CC=4C=CC=CC=4)C[C@@H]3CC2)CCOCC1 NUBHGCWUZZYQCT-AFXVXQJMSA-N 0.000 claims 1
- DFHVCZMXZUUYEF-KEZOAJOQSA-N (2s)-n-[(3as,4r,6ar)-2-benzyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-4-methyl-2-piperidin-1-ylpentanamide Chemical compound N1([C@@H](CC(C)C)C(=O)N[C@H]2[C@@H]3CN(CC=4C=CC=CC=4)C[C@@H]3CC2)CCCCC1 DFHVCZMXZUUYEF-KEZOAJOQSA-N 0.000 claims 1
- MMAPUUNPFVWZNT-AFXVXQJMSA-N (2s)-n-[(3as,4r,6ar)-2-benzyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-4-methyl-2-pyrrolidin-1-ylpentanamide Chemical compound N1([C@@H](CC(C)C)C(=O)N[C@H]2[C@@H]3CN(CC=4C=CC=CC=4)C[C@@H]3CC2)CCCC1 MMAPUUNPFVWZNT-AFXVXQJMSA-N 0.000 claims 1
- FDNJHAFULMBTQR-MANSERQUSA-N (2s)-n-[(3as,4r,6ar)-2-benzyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]piperidine-2-carboxamide Chemical compound C([C@@H]1CC[C@H]([C@@H]1C1)NC(=O)[C@H]2NCCCC2)N1CC1=CC=CC=C1 FDNJHAFULMBTQR-MANSERQUSA-N 0.000 claims 1
- QOBBCGKBMUMPEY-AITUJVMLSA-N (2s)-n-[(3as,4r,6ar)-2-cyclopropylsulfonyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-4-methyl-2-pyrrolidin-1-ylpentanamide Chemical compound N1([C@@H](CC(C)C)C(=O)N[C@H]2[C@@H]3CN(C[C@@H]3CC2)S(=O)(=O)C2CC2)CCCC1 QOBBCGKBMUMPEY-AITUJVMLSA-N 0.000 claims 1
- UEDWLWBUBRWATL-HZMVEIRTSA-N (2s)-n-[(3as,4r,6ar)-2-methylsulfonyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-4-methyl-2-pyrrolidin-1-ylpentanamide Chemical compound N1([C@@H](CC(C)C)C(=O)N[C@H]2[C@@H]3CN(C[C@@H]3CC2)S(C)(=O)=O)CCCC1 UEDWLWBUBRWATL-HZMVEIRTSA-N 0.000 claims 1
- DGNINGBAZJPLSW-INWMFGNUSA-N (3ar,4s,6as)-2-[2-chloro-4-(trifluoromethyl)phenyl]sulfonyl-n,n-diethyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-amine Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)N(CC)CC)N1S(=O)(=O)C1=CC=C(C(F)(F)F)C=C1Cl DGNINGBAZJPLSW-INWMFGNUSA-N 0.000 claims 1
- XKAWHGWXUGNVQR-WPGHFRTFSA-N (3ar,4s,6as)-2-[2-chloro-4-(trifluoromethyl)phenyl]sulfonyl-n-[5-(trifluoromethyl)pyridin-2-yl]-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-amine Chemical compound N1=CC(C(F)(F)F)=CC=C1N[C@@H]1[C@H]2CN(S(=O)(=O)C=3C(=CC(=CC=3)C(F)(F)F)Cl)C[C@H]2CC1 XKAWHGWXUGNVQR-WPGHFRTFSA-N 0.000 claims 1
- RXWBIZNXTMGFAV-OSMZGAPFSA-N (3ar,4s,6as)-2-[2-chloro-4-(trifluoromethyl)phenyl]sulfonyl-n-ethyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-amine Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)NCC)N1S(=O)(=O)C1=CC=C(C(F)(F)F)C=C1Cl RXWBIZNXTMGFAV-OSMZGAPFSA-N 0.000 claims 1
- BPRGUKOJPVNZHW-ZLDLUXBVSA-N (3ar,4s,6as)-2-[2-chloro-4-(trifluoromethyl)phenyl]sulfonyl-n-propan-2-yl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-amine Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)NC(C)C)N1S(=O)(=O)C1=CC=C(C(F)(F)F)C=C1Cl BPRGUKOJPVNZHW-ZLDLUXBVSA-N 0.000 claims 1
- FITQSMLAXUKLFQ-COXVUDFISA-N (3ar,4s,6as)-n,n-diethyl-2-[4-(trifluoromethyl)phenyl]sulfonyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-amine Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)N(CC)CC)N1S(=O)(=O)C1=CC=C(C(F)(F)F)C=C1 FITQSMLAXUKLFQ-COXVUDFISA-N 0.000 claims 1
- CBPRNNOYAVPDGZ-MNEFBYGVSA-N (3ar,4s,6as)-n,n-dipropyl-2-[4-(trifluoromethyl)phenyl]sulfonyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-amine Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)N(CCC)CCC)N1S(=O)(=O)C1=CC=C(C(F)(F)F)C=C1 CBPRNNOYAVPDGZ-MNEFBYGVSA-N 0.000 claims 1
- CIGFQFVFBZTNRV-COXVUDFISA-N (3ar,4s,6as)-n-(2,2-dimethylpropyl)-2-[3-(trifluoromethyl)phenyl]sulfonyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-amine Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)NCC(C)(C)C)N1S(=O)(=O)C1=CC=CC(C(F)(F)F)=C1 CIGFQFVFBZTNRV-COXVUDFISA-N 0.000 claims 1
- HXUCCGOSVVJMFY-COXVUDFISA-N (3ar,4s,6as)-n-(cyclopropylmethyl)-2-[4-(trifluoromethyl)phenyl]sulfonyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-amine Chemical compound C1=CC(C(F)(F)F)=CC=C1S(=O)(=O)N1C[C@@H]2[C@@H](NCC3CC3)CC[C@@H]2C1 HXUCCGOSVVJMFY-COXVUDFISA-N 0.000 claims 1
- URXRWNXPITVUKA-XPGWFJOJSA-N (3ar,4s,6as)-n-[(4-fluorophenyl)methyl]-2-[3-(trifluoromethyl)phenyl]sulfonyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-amine Chemical compound C1=CC(F)=CC=C1CN[C@@H]1[C@H]2CN(S(=O)(=O)C=3C=C(C=CC=3)C(F)(F)F)C[C@H]2CC1 URXRWNXPITVUKA-XPGWFJOJSA-N 0.000 claims 1
- DQBXHRDAIPITIH-QMMLZNLJSA-N (3ar,4s,6as)-n-[(4-fluorophenyl)methyl]-2-[[3-(trifluoromethyl)phenyl]methyl]-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-amine Chemical compound C1=CC(F)=CC=C1CN[C@@H]1[C@H]2CN(CC=3C=C(C=CC=3)C(F)(F)F)C[C@H]2CC1 DQBXHRDAIPITIH-QMMLZNLJSA-N 0.000 claims 1
- XWKIFTLWTYFSNT-UGFHNGPFSA-N (3ar,4s,6as)-n-ethyl-2-[4-(trifluoromethyl)phenyl]sulfonyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-amine Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)NCC)N1S(=O)(=O)C1=CC=C(C(F)(F)F)C=C1 XWKIFTLWTYFSNT-UGFHNGPFSA-N 0.000 claims 1
- JMJHLMPETGIHCV-SWHYSGLUSA-N (3ar,4s,6as)-n-methyl-2-[4-(trifluoromethyl)phenyl]sulfonyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-amine Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)NC)N1S(=O)(=O)C1=CC=C(C(F)(F)F)C=C1 JMJHLMPETGIHCV-SWHYSGLUSA-N 0.000 claims 1
- SWFXMIGUCCHROZ-KCXAZCMYSA-N (3ar,4s,6as)-n-propan-2-yl-2-[4-(trifluoromethyl)phenyl]sulfonyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-amine Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)NC(C)C)N1S(=O)(=O)C1=CC=C(C(F)(F)F)C=C1 SWFXMIGUCCHROZ-KCXAZCMYSA-N 0.000 claims 1
- NPSZXGUAPAPUOE-KCXAZCMYSA-N (3ar,4s,6as)-n-propyl-2-[4-(trifluoromethyl)phenyl]sulfonyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-amine Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)NCCC)N1S(=O)(=O)C1=CC=C(C(F)(F)F)C=C1 NPSZXGUAPAPUOE-KCXAZCMYSA-N 0.000 claims 1
- CIGFQFVFBZTNRV-IAOVAPTHSA-N (3as,4r,6ar)-n-(2,2-dimethylpropyl)-2-[3-(trifluoromethyl)phenyl]sulfonyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-amine Chemical compound C([C@@H]1CC[C@H]([C@@H]1C1)NCC(C)(C)C)N1S(=O)(=O)C1=CC=CC(C(F)(F)F)=C1 CIGFQFVFBZTNRV-IAOVAPTHSA-N 0.000 claims 1
- 125000001637 1-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C(*)=C([H])C([H])=C([H])C2=C1[H] 0.000 claims 1
- SDQJTWBNWQABLE-UHFFFAOYSA-N 1h-quinazoline-2,4-dione Chemical compound C1=CC=C2C(=O)NC(=O)NC2=C1 SDQJTWBNWQABLE-UHFFFAOYSA-N 0.000 claims 1
- 125000004847 2-fluorobenzyl group Chemical group [H]C1=C([H])C(F)=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 claims 1
- 125000004189 3,4-dichlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(Cl)C([H])=C1* 0.000 claims 1
- 125000003762 3,4-dimethoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1* 0.000 claims 1
- 125000004211 3,5-difluorophenyl group Chemical group [H]C1=C(F)C([H])=C(*)C([H])=C1F 0.000 claims 1
- GCFIYMRCJOPFEL-PUHATCMVSA-N 3-[(3ar,4s,6as)-2-benzyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-1-phenyl-1-propan-2-ylurea Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)NC(=O)N(C(C)C)C=2C=CC=CC=2)N1CC1=CC=CC=C1 GCFIYMRCJOPFEL-PUHATCMVSA-N 0.000 claims 1
- 125000006275 3-bromophenyl group Chemical group [H]C1=C([H])C(Br)=C([H])C(*)=C1[H] 0.000 claims 1
- 125000006284 3-fluorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C(F)=C1[H])C([H])([H])* 0.000 claims 1
- 125000006180 3-methyl benzyl group Chemical group [H]C1=C([H])C(=C([H])C(=C1[H])C([H])([H])[H])C([H])([H])* 0.000 claims 1
- 125000006201 3-phenylpropyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- 125000004801 4-cyanophenyl group Chemical group [H]C1=C([H])C(C#N)=C([H])C([H])=C1* 0.000 claims 1
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 claims 1
- 125000006181 4-methyl benzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])C([H])([H])* 0.000 claims 1
- UIRSLBDCOYTZPH-UHFFFAOYSA-N 4h-1,4-thiazin-3-one Chemical compound O=C1CSC=CN1 UIRSLBDCOYTZPH-UHFFFAOYSA-N 0.000 claims 1
- 206010065040 AIDS dementia complex Diseases 0.000 claims 1
- 208000024827 Alzheimer disease Diseases 0.000 claims 1
- 206010002388 Angina unstable Diseases 0.000 claims 1
- 208000019901 Anxiety disease Diseases 0.000 claims 1
- 201000001320 Atherosclerosis Diseases 0.000 claims 1
- 208000008035 Back Pain Diseases 0.000 claims 1
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 claims 1
- 206010058019 Cancer Pain Diseases 0.000 claims 1
- 208000024172 Cardiovascular disease Diseases 0.000 claims 1
- 208000000094 Chronic Pain Diseases 0.000 claims 1
- 206010012289 Dementia Diseases 0.000 claims 1
- 206010012434 Dermatitis allergic Diseases 0.000 claims 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims 1
- 208000001640 Fibromyalgia Diseases 0.000 claims 1
- 206010019196 Head injury Diseases 0.000 claims 1
- 206010019233 Headaches Diseases 0.000 claims 1
- 206010019280 Heart failures Diseases 0.000 claims 1
- 208000004454 Hyperalgesia Diseases 0.000 claims 1
- 206010020772 Hypertension Diseases 0.000 claims 1
- 206010020853 Hypertonic bladder Diseases 0.000 claims 1
- 206010061218 Inflammation Diseases 0.000 claims 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 1
- 206010065390 Inflammatory pain Diseases 0.000 claims 1
- 208000005615 Interstitial Cystitis Diseases 0.000 claims 1
- GOFKPPAWQIPWRM-UHFFFAOYSA-N NC(CC1)C(C2)C1C(CC(C=C1)=CC=C1F)N2S(C1=CC(C(F)(F)F)=CC=C1)(=O)=O Chemical compound NC(CC1)C(C2)C1C(CC(C=C1)=CC=C1F)N2S(C1=CC(C(F)(F)F)=CC=C1)(=O)=O GOFKPPAWQIPWRM-UHFFFAOYSA-N 0.000 claims 1
- 208000012902 Nervous system disease Diseases 0.000 claims 1
- 208000009722 Overactive Urinary Bladder Diseases 0.000 claims 1
- 208000018737 Parkinson disease Diseases 0.000 claims 1
- 208000004403 Prostatic Hyperplasia Diseases 0.000 claims 1
- 206010036968 Prostatic pain Diseases 0.000 claims 1
- 208000003251 Pruritus Diseases 0.000 claims 1
- 208000028017 Psychotic disease Diseases 0.000 claims 1
- 208000008765 Sciatica Diseases 0.000 claims 1
- 201000001880 Sexual dysfunction Diseases 0.000 claims 1
- 208000006011 Stroke Diseases 0.000 claims 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 claims 1
- 208000007814 Unstable Angina Diseases 0.000 claims 1
- 208000026723 Urinary tract disease Diseases 0.000 claims 1
- ZUSWDTWYONAOPH-UHFFFAOYSA-N [2-(trifluoromethyl)phenyl]hydrazine;hydrochloride Chemical group [Cl-].[NH3+]NC1=CC=CC=C1C(F)(F)F ZUSWDTWYONAOPH-UHFFFAOYSA-N 0.000 claims 1
- 208000005298 acute pain Diseases 0.000 claims 1
- 125000002947 alkylene group Chemical group 0.000 claims 1
- 206010053552 allodynia Diseases 0.000 claims 1
- 230000036506 anxiety Effects 0.000 claims 1
- 206010003119 arrhythmia Diseases 0.000 claims 1
- 230000006793 arrhythmia Effects 0.000 claims 1
- 208000006673 asthma Diseases 0.000 claims 1
- 201000008937 atopic dermatitis Diseases 0.000 claims 1
- 208000010668 atopic eczema Diseases 0.000 claims 1
- 208000028683 bipolar I disease Diseases 0.000 claims 1
- 208000026106 cerebrovascular disease Diseases 0.000 claims 1
- PNZXMIKHJXIPEK-UHFFFAOYSA-N cyclohexanecarboxamide Chemical compound NC(=O)C1CCCCC1 PNZXMIKHJXIPEK-UHFFFAOYSA-N 0.000 claims 1
- 125000006312 cyclopentyl amino group Chemical group [H]N(*)C1([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 206010015037 epilepsy Diseases 0.000 claims 1
- 231100000869 headache Toxicity 0.000 claims 1
- 150000002430 hydrocarbons Chemical group 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- 208000000509 infertility Diseases 0.000 claims 1
- 230000036512 infertility Effects 0.000 claims 1
- 231100000535 infertility Toxicity 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 claims 1
- 201000004332 intermediate coronary syndrome Diseases 0.000 claims 1
- 208000002551 irritable bowel syndrome Diseases 0.000 claims 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims 1
- YAYWAEXAPGFIKA-UHFFFAOYSA-N n-(1,2,3,3a,4,5,6,6a-octahydrocyclopenta[c]pyrrol-4-yl)acetamide Chemical compound C1NCC2C(NC(=O)C)CCC21 YAYWAEXAPGFIKA-UHFFFAOYSA-N 0.000 claims 1
- OCKCLLMPGDCTOY-UHFFFAOYSA-N n-(2-trityl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl)acetamide Chemical compound C1C2C(NC(=O)C)CCC2CN1C(C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 OCKCLLMPGDCTOY-UHFFFAOYSA-N 0.000 claims 1
- FJAOHSBTUVUJTC-DMTNHVFBSA-N n-[(3ar,4r,6as)-2-[[3-(trifluoromethyl)phenyl]methyl]-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-2,2-dicyclohexylacetamide Chemical compound FC(F)(F)C1=CC=CC(CN2C[C@@H]3[C@H](NC(=O)C(C4CCCCC4)C4CCCCC4)CC[C@@H]3C2)=C1 FJAOHSBTUVUJTC-DMTNHVFBSA-N 0.000 claims 1
- JIOAYGJLFFPJCD-XXRNLSRLSA-N n-[(3ar,4s,6as)-2-(2-phenylethyl)-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-3-methyl-2-phenylbutanamide Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)NC(=O)C(C(C)C)C=2C=CC=CC=2)N1CCC1=CC=CC=C1 JIOAYGJLFFPJCD-XXRNLSRLSA-N 0.000 claims 1
- HANJFSRUVQXSSI-VPLDAIPJSA-N n-[(3ar,4s,6as)-2-(3,3-diphenylpropyl)-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-3-methyl-2-phenylbutanamide Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)NC(=O)C(C(C)C)C=2C=CC=CC=2)N1CCC(C=1C=CC=CC=1)C1=CC=CC=C1 HANJFSRUVQXSSI-VPLDAIPJSA-N 0.000 claims 1
- ZMSLVBUSOKGTIX-VHNWMKGBSA-N n-[(3ar,4s,6as)-2-(3-phenylpropyl)-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-3-methyl-2-phenylbutanamide Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)NC(=O)C(C(C)C)C=2C=CC=CC=2)N1CCCC1=CC=CC=C1 ZMSLVBUSOKGTIX-VHNWMKGBSA-N 0.000 claims 1
- RRMJHLSNYMGOPL-RAMLRSSZSA-N n-[(3ar,4s,6as)-2-(4-phenylbutyl)-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-3-methyl-2-phenylbutanamide Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)NC(=O)C(C(C)C)C=2C=CC=CC=2)N1CCCCC1=CC=CC=C1 RRMJHLSNYMGOPL-RAMLRSSZSA-N 0.000 claims 1
- YUUJUZISPXRYAI-XDXUOVRZSA-N n-[(3ar,4s,6as)-2-(cyclohexylmethyl)-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-3-methyl-2-phenylbutanamide Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)NC(=O)C(C(C)C)C=2C=CC=CC=2)N1CC1CCCCC1 YUUJUZISPXRYAI-XDXUOVRZSA-N 0.000 claims 1
- HUXYJUZVLBYWPQ-ZFSMBLLKSA-N n-[(3ar,4s,6as)-2-(pyridin-4-ylmethyl)-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-3-methyl-2-phenylbutanamide Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)NC(=O)C(C(C)C)C=2C=CC=CC=2)N1CC1=CC=NC=C1 HUXYJUZVLBYWPQ-ZFSMBLLKSA-N 0.000 claims 1
- OVAPAQNIPRSOLR-UZGMISGMSA-N n-[(3ar,4s,6as)-2-[(2,6-dimethylphenyl)methyl]-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-3-methyl-2-phenylbutanamide Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)NC(=O)C(C(C)C)C=2C=CC=CC=2)N1CC1=C(C)C=CC=C1C OVAPAQNIPRSOLR-UZGMISGMSA-N 0.000 claims 1
- VGTGTHAIRRRVEL-ZRSRXCJOSA-N n-[(3ar,4s,6as)-2-[(2-fluorophenyl)methyl]-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-3-methyl-2-phenylbutanamide Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)NC(=O)C(C(C)C)C=2C=CC=CC=2)N1CC1=CC=CC=C1F VGTGTHAIRRRVEL-ZRSRXCJOSA-N 0.000 claims 1
- IHCCXRCDMCIMIE-TXAIJMKWSA-N n-[(3ar,4s,6as)-2-[(2-methoxyphenyl)methyl]-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-3-methyl-2-phenylbutanamide Chemical compound COC1=CC=CC=C1CN1C[C@@H]2[C@@H](NC(=O)C(C(C)C)C=3C=CC=CC=3)CC[C@@H]2C1 IHCCXRCDMCIMIE-TXAIJMKWSA-N 0.000 claims 1
- GJIXUYGAHFEUBF-XXRNLSRLSA-N n-[(3ar,4s,6as)-2-[(2-methylphenyl)methyl]-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-3-methyl-2-phenylbutanamide Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)NC(=O)C(C(C)C)C=2C=CC=CC=2)N1CC1=CC=CC=C1C GJIXUYGAHFEUBF-XXRNLSRLSA-N 0.000 claims 1
- MAOXRKYQZUJXKD-JDMZLTFJSA-N n-[(3ar,4s,6as)-2-[(3-chlorophenyl)methyl]-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-3-methyl-2-phenylbutanamide Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)NC(=O)C(C(C)C)C=2C=CC=CC=2)N1CC1=CC=CC(Cl)=C1 MAOXRKYQZUJXKD-JDMZLTFJSA-N 0.000 claims 1
- LUQLTSLZPLBFFI-XXRNLSRLSA-N n-[(3ar,4s,6as)-2-[(3-cyanophenyl)methyl]-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-3-methyl-2-phenylbutanamide Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)NC(=O)C(C(C)C)C=2C=CC=CC=2)N1CC1=CC=CC(C#N)=C1 LUQLTSLZPLBFFI-XXRNLSRLSA-N 0.000 claims 1
- PWFNTVANCIZBJX-JDMZLTFJSA-N n-[(3ar,4s,6as)-2-[(3-fluorophenyl)methyl]-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-3-methyl-2-phenylbutanamide Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)NC(=O)C(C(C)C)C=2C=CC=CC=2)N1CC1=CC=CC(F)=C1 PWFNTVANCIZBJX-JDMZLTFJSA-N 0.000 claims 1
- TVOMECBVBWXSGL-GHQYHPDKSA-N n-[(3ar,4s,6as)-2-[(3-methoxyphenyl)methyl]-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-3-methyl-2-phenylbutanamide Chemical compound COC1=CC=CC(CN2C[C@@H]3[C@@H](NC(=O)C(C(C)C)C=4C=CC=CC=4)CC[C@@H]3C2)=C1 TVOMECBVBWXSGL-GHQYHPDKSA-N 0.000 claims 1
- NXIYHDYHQSJTOR-XXRNLSRLSA-N n-[(3ar,4s,6as)-2-[(3-methylphenyl)methyl]-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-3-methyl-2-phenylbutanamide Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)NC(=O)C(C(C)C)C=2C=CC=CC=2)N1CC1=CC=CC(C)=C1 NXIYHDYHQSJTOR-XXRNLSRLSA-N 0.000 claims 1
- QLPJZODWUAYBHI-JDMZLTFJSA-N n-[(3ar,4s,6as)-2-[(4-fluorophenyl)methyl]-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-3-methyl-2-phenylbutanamide Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)NC(=O)C(C(C)C)C=2C=CC=CC=2)N1CC1=CC=C(F)C=C1 QLPJZODWUAYBHI-JDMZLTFJSA-N 0.000 claims 1
- ZAVUMMFYXCLOTB-GHQYHPDKSA-N n-[(3ar,4s,6as)-2-[(4-methoxyphenyl)methyl]-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-3-methyl-2-phenylbutanamide Chemical compound C1=CC(OC)=CC=C1CN1C[C@@H]2[C@@H](NC(=O)C(C(C)C)C=3C=CC=CC=3)CC[C@@H]2C1 ZAVUMMFYXCLOTB-GHQYHPDKSA-N 0.000 claims 1
- JDQZCHXZMZIZEX-BVKBALMLSA-N n-[(3ar,4s,6as)-2-[(4-tert-butylphenyl)methyl]-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-3-methyl-2-phenylbutanamide Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)NC(=O)C(C(C)C)C=2C=CC=CC=2)N1CC1=CC=C(C(C)(C)C)C=C1 JDQZCHXZMZIZEX-BVKBALMLSA-N 0.000 claims 1
- MNTNDQRWOGRYMW-KVYFGCOSSA-N n-[(3ar,4s,6as)-2-[3,3-bis(4-fluorophenyl)propyl]-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-3-methyl-2-phenylbutanamide Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)NC(=O)C(C(C)C)C=2C=CC=CC=2)N1CCC(C=1C=CC(F)=CC=1)C1=CC=C(F)C=C1 MNTNDQRWOGRYMW-KVYFGCOSSA-N 0.000 claims 1
- GOCBIHNWMDBMGM-RAMLRSSZSA-N n-[(3ar,4s,6as)-2-[3-(2-methylphenyl)propyl]-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-3-methyl-2-phenylbutanamide Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)NC(=O)C(C(C)C)C=2C=CC=CC=2)N1CCCC1=CC=CC=C1C GOCBIHNWMDBMGM-RAMLRSSZSA-N 0.000 claims 1
- YDWIXNYGPSXIRF-UZGMISGMSA-N n-[(3ar,4s,6as)-2-[3-(3-chlorophenyl)propyl]-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-3-methyl-2-phenylbutanamide Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)NC(=O)C(C(C)C)C=2C=CC=CC=2)N1CCCC1=CC=CC(Cl)=C1 YDWIXNYGPSXIRF-UZGMISGMSA-N 0.000 claims 1
- BFMZOFRSTNVLKU-UZGMISGMSA-N n-[(3ar,4s,6as)-2-[3-(3-fluorophenyl)propyl]-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-3-methyl-2-phenylbutanamide Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)NC(=O)C(C(C)C)C=2C=CC=CC=2)N1CCCC1=CC=CC(F)=C1 BFMZOFRSTNVLKU-UZGMISGMSA-N 0.000 claims 1
- DEWZDZQKZHTKMB-RAMLRSSZSA-N n-[(3ar,4s,6as)-2-[3-(3-methylphenyl)propyl]-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-3-methyl-2-phenylbutanamide Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)NC(=O)C(C(C)C)C=2C=CC=CC=2)N1CCCC1=CC=CC(C)=C1 DEWZDZQKZHTKMB-RAMLRSSZSA-N 0.000 claims 1
- RNDDOHQGBFHRRD-PLFRKVQXSA-N n-[(3ar,4s,6as)-2-[3-(4-tert-butylphenyl)propyl]-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-3-methyl-2-phenylbutanamide Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)NC(=O)C(C(C)C)C=2C=CC=CC=2)N1CCCC1=CC=C(C(C)(C)C)C=C1 RNDDOHQGBFHRRD-PLFRKVQXSA-N 0.000 claims 1
- NDMXQOUDOHEXMV-UZGMISGMSA-N n-[(3ar,4s,6as)-2-[3-[3-(trifluoromethyl)phenyl]propyl]-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-3-methyl-2-phenylbutanamide Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)NC(=O)C(C(C)C)C=2C=CC=CC=2)N1CCCC1=CC=CC(C(F)(F)F)=C1 NDMXQOUDOHEXMV-UZGMISGMSA-N 0.000 claims 1
- VTWSFYYTEQRDKR-UZGMISGMSA-N n-[(3ar,4s,6as)-2-[3-[4-(trifluoromethyl)phenyl]propyl]-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-3-methyl-2-phenylbutanamide Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)NC(=O)C(C(C)C)C=2C=CC=CC=2)N1CCCC1=CC=C(C(F)(F)F)C=C1 VTWSFYYTEQRDKR-UZGMISGMSA-N 0.000 claims 1
- LIDPUHPUOYOHKJ-HOMPBRHSSA-N n-[(3ar,4s,6as)-2-[4,4-bis(4-fluorophenyl)butyl]-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-3-methyl-2-phenylbutanamide Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)NC(=O)C(C(C)C)C=2C=CC=CC=2)N1CCCC(C=1C=CC(F)=CC=1)C1=CC=C(F)C=C1 LIDPUHPUOYOHKJ-HOMPBRHSSA-N 0.000 claims 1
- SYQKRALDUSLNEI-COXVUDFISA-N n-[(3ar,4s,6as)-2-[4-(trifluoromethyl)phenyl]sulfonyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-2-nitrobenzenesulfonamide Chemical compound [O-][N+](=O)C1=CC=CC=C1S(=O)(=O)N[C@@H]1[C@H]2CN(S(=O)(=O)C=3C=CC(=CC=3)C(F)(F)F)C[C@H]2CC1 SYQKRALDUSLNEI-COXVUDFISA-N 0.000 claims 1
- GOVBSNDWEVMCCG-JLSDUUJJSA-N n-[(3ar,4s,6as)-2-[4-(trifluoromethyl)phenyl]sulfonyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-n-methyl-2-nitrobenzenesulfonamide Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)N(C)S(=O)(=O)C=2C(=CC=CC=2)[N+]([O-])=O)N1S(=O)(=O)C1=CC=C(C(F)(F)F)C=C1 GOVBSNDWEVMCCG-JLSDUUJJSA-N 0.000 claims 1
- HAGVAOVIOPYLKI-BYKNITIXSA-N n-[(3ar,4s,6as)-2-[5,5-bis(4-fluorophenyl)pentyl]-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-3-methyl-2-phenylbutanamide Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)NC(=O)C(C(C)C)C=2C=CC=CC=2)N1CCCCC(C=1C=CC(F)=CC=1)C1=CC=C(F)C=C1 HAGVAOVIOPYLKI-BYKNITIXSA-N 0.000 claims 1
- BRFLFYAITKCSIZ-GYGZHRCXSA-N n-[(3ar,4s,6as)-2-[6,6-bis(4-fluorophenyl)hexyl]-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-3-methyl-2-phenylbutanamide Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)NC(=O)C(C(C)C)C=2C=CC=CC=2)N1CCCCCC(C=1C=CC(F)=CC=1)C1=CC=C(F)C=C1 BRFLFYAITKCSIZ-GYGZHRCXSA-N 0.000 claims 1
- CCFLIQFJRUCFCB-KBMXLJTQSA-N n-[(3ar,4s,6as)-2-[6-(trifluoromethyl)pyridin-2-yl]-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-4-fluorobenzamide Chemical compound C1=CC(F)=CC=C1C(=O)N[C@@H]1[C@H]2CN(C=3N=C(C=CC=3)C(F)(F)F)C[C@H]2CC1 CCFLIQFJRUCFCB-KBMXLJTQSA-N 0.000 claims 1
- WRHXIEPCASAPCY-ZRSRXCJOSA-N n-[(3ar,4s,6as)-2-[[2-(trifluoromethyl)phenyl]methyl]-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-3-methyl-2-phenylbutanamide Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)NC(=O)C(C(C)C)C=2C=CC=CC=2)N1CC1=CC=CC=C1C(F)(F)F WRHXIEPCASAPCY-ZRSRXCJOSA-N 0.000 claims 1
- DYRMMCRLIMMOJL-LSSMUYGWSA-N n-[(3ar,4s,6as)-2-[[3-fluoro-4-(trifluoromethyl)phenyl]methyl]-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-3-methyl-2-phenylbutanamide Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)NC(=O)C(C(C)C)C=2C=CC=CC=2)N1CC1=CC=C(C(F)(F)F)C(F)=C1 DYRMMCRLIMMOJL-LSSMUYGWSA-N 0.000 claims 1
- FBUNVEFOYSAPBM-LSSMUYGWSA-N n-[(3ar,4s,6as)-2-[[4-fluoro-3-(trifluoromethyl)phenyl]methyl]-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-3-methyl-2-phenylbutanamide Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)NC(=O)C(C(C)C)C=2C=CC=CC=2)N1CC1=CC=C(F)C(C(F)(F)F)=C1 FBUNVEFOYSAPBM-LSSMUYGWSA-N 0.000 claims 1
- NATSUVQXKCVDKZ-ZFSMBLLKSA-N n-[(3ar,4s,6as)-2-benzoyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-3-methyl-2-phenylbutanamide Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)NC(=O)C(C(C)C)C=2C=CC=CC=2)N1C(=O)C1=CC=CC=C1 NATSUVQXKCVDKZ-ZFSMBLLKSA-N 0.000 claims 1
- NWOTVJCUJHEELF-VJTSUQJLSA-N n-[(3ar,4s,6as)-2-benzyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-1-phenylcyclohexane-1-carboxamide Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)NC(=O)C2(CCCCC2)C=2C=CC=CC=2)N1CC1=CC=CC=C1 NWOTVJCUJHEELF-VJTSUQJLSA-N 0.000 claims 1
- MASLRAWNNPKERH-HJNYFJLDSA-N n-[(3ar,4s,6as)-2-benzyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-1-phenylcyclopropane-1-carboxamide Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)NC(=O)C2(CC2)C=2C=CC=CC=2)N1CC1=CC=CC=C1 MASLRAWNNPKERH-HJNYFJLDSA-N 0.000 claims 1
- IQEVAHZYBSUYPP-RZFJZAQRSA-N n-[(3ar,4s,6as)-2-benzyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-2,2-bis(4-fluorophenyl)acetamide Chemical compound C1=CC(F)=CC=C1C(C=1C=CC(F)=CC=1)C(=O)N[C@@H]1[C@H]2CN(CC=3C=CC=CC=3)C[C@H]2CC1 IQEVAHZYBSUYPP-RZFJZAQRSA-N 0.000 claims 1
- USIBBSAAJMNUPN-ZNZIZOMTSA-N n-[(3ar,4s,6as)-2-benzyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-2,2-dicyclohexylacetamide Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)NC(=O)C(C2CCCCC2)C2CCCCC2)N1CC1=CC=CC=C1 USIBBSAAJMNUPN-ZNZIZOMTSA-N 0.000 claims 1
- KQQJEVURYCVLGV-LBSFNXSNSA-N n-[(3ar,4s,6as)-2-benzyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-2,3-diphenylpropanamide Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)NC(=O)C(CC=2C=CC=CC=2)C=2C=CC=CC=2)N1CC1=CC=CC=C1 KQQJEVURYCVLGV-LBSFNXSNSA-N 0.000 claims 1
- MMRDVXCWKZHBDM-JDMZLTFJSA-N n-[(3ar,4s,6as)-2-benzyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-2-(4-chlorophenyl)-3-methylbutanamide Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)NC(=O)C(C(C)C)C=2C=CC(Cl)=CC=2)N1CC1=CC=CC=C1 MMRDVXCWKZHBDM-JDMZLTFJSA-N 0.000 claims 1
- STTSBVHXFVXHRR-JDMZLTFJSA-N n-[(3ar,4s,6as)-2-benzyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-2-(4-hydroxyphenyl)-3-methylbutanamide Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)NC(=O)C(C(C)C)C=2C=CC(O)=CC=2)N1CC1=CC=CC=C1 STTSBVHXFVXHRR-JDMZLTFJSA-N 0.000 claims 1
- JYMDHABUCGOMGF-JJZURMAISA-N n-[(3ar,4s,6as)-2-benzyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-2-benzyl-3,3-dimethylbutanamide Chemical compound N([C@@H]1[C@H]2CN(CC=3C=CC=CC=3)C[C@H]2CC1)C(=O)C(C(C)(C)C)CC1=CC=CC=C1 JYMDHABUCGOMGF-JJZURMAISA-N 0.000 claims 1
- JEXAZUMKXNHAFK-XXRNLSRLSA-N n-[(3ar,4s,6as)-2-benzyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-2-cyclobutyl-2-phenylacetamide Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)NC(=O)C(C2CCC2)C=2C=CC=CC=2)N1CC1=CC=CC=C1 JEXAZUMKXNHAFK-XXRNLSRLSA-N 0.000 claims 1
- BDECLCVAQQPYIA-VHNWMKGBSA-N n-[(3ar,4s,6as)-2-benzyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-2-cyclopentyl-2-phenylacetamide Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)NC(=O)C(C2CCCC2)C=2C=CC=CC=2)N1CC1=CC=CC=C1 BDECLCVAQQPYIA-VHNWMKGBSA-N 0.000 claims 1
- WJJWYFRYFSYNPN-XDXUOVRZSA-N n-[(3ar,4s,6as)-2-benzyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-2-cyclopropyl-2-phenylacetamide Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)NC(=O)C(C2CC2)C=2C=CC=CC=2)N1CC1=CC=CC=C1 WJJWYFRYFSYNPN-XDXUOVRZSA-N 0.000 claims 1
- ZOWLHDAHUAMRTQ-HJNYFJLDSA-N n-[(3ar,4s,6as)-2-benzyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-2-methyl-2-phenylpropanamide Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)NC(=O)C(C)(C)C=2C=CC=CC=2)N1CC1=CC=CC=C1 ZOWLHDAHUAMRTQ-HJNYFJLDSA-N 0.000 claims 1
- GGTHRHXEGUHINV-NSGAJXJNSA-N n-[(3ar,4s,6as)-2-benzyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-2-methyl-3-phenylpropanamide Chemical compound N([C@@H]1[C@H]2CN(CC=3C=CC=CC=3)C[C@H]2CC1)C(=O)C(C)CC1=CC=CC=C1 GGTHRHXEGUHINV-NSGAJXJNSA-N 0.000 claims 1
- ZHCVAQPWDAYWNI-XDXUOVRZSA-N n-[(3ar,4s,6as)-2-benzyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-3,3-dimethyl-2-phenylbutanamide Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)NC(=O)C(C(C)(C)C)C=2C=CC=CC=2)N1CC1=CC=CC=C1 ZHCVAQPWDAYWNI-XDXUOVRZSA-N 0.000 claims 1
- AEHLVQDFIMVPSJ-VHNWMKGBSA-N n-[(3ar,4s,6as)-2-benzyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-3-ethyl-2-phenylpentanamide Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)NC(=O)C(C(CC)CC)C=2C=CC=CC=2)N1CC1=CC=CC=C1 AEHLVQDFIMVPSJ-VHNWMKGBSA-N 0.000 claims 1
- HEVYJRZHYSRHDM-XDXUOVRZSA-N n-[(3ar,4s,6as)-2-benzyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-3-methyl-2-phenylbutanamide Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)NC(=O)C(C(C)C)C=2C=CC=CC=2)N1CC1=CC=CC=C1 HEVYJRZHYSRHDM-XDXUOVRZSA-N 0.000 claims 1
- PDFATPKTQIBOSI-AABGKKOBSA-N n-[(3ar,4s,6as)-2-benzyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-3-methyl-2-propan-2-ylbutanamide Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)NC(=O)C(C(C)C)C(C)C)N1CC1=CC=CC=C1 PDFATPKTQIBOSI-AABGKKOBSA-N 0.000 claims 1
- IHQZJMDOKJOKIE-SQNIBIBYSA-N n-[(3ar,4s,6as)-2-benzyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-3-methylbutanamide Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)NC(=O)CC(C)C)N1CC1=CC=CC=C1 IHQZJMDOKJOKIE-SQNIBIBYSA-N 0.000 claims 1
- CNBIUZXLXDADDC-XXRNLSRLSA-N n-[(3ar,4s,6as)-2-benzyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-n,3-dimethyl-2-phenylbutanamide Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)N(C)C(=O)C(C(C)C)C=2C=CC=CC=2)N1CC1=CC=CC=C1 CNBIUZXLXDADDC-XXRNLSRLSA-N 0.000 claims 1
- BGZOADFLQOFKNC-KKSQLVLISA-N n-[(3ar,4s,6as)-2-methyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-3-methyl-2-phenylbutanamide Chemical compound N([C@@H]1[C@H]2CN(C)C[C@H]2CC1)C(=O)C(C(C)C)C1=CC=CC=C1 BGZOADFLQOFKNC-KKSQLVLISA-N 0.000 claims 1
- LCHOSRIKTHYCQA-IPMKNSEASA-N n-[(3as,4r,6ar)-1,2,3,3a,4,5,6,6a-octahydrocyclopenta[c]pyrrol-4-yl]-2,2-dicyclohexylacetamide Chemical compound N([C@H]1[C@@H]2CNC[C@@H]2CC1)C(=O)C(C1CCCCC1)C1CCCCC1 LCHOSRIKTHYCQA-IPMKNSEASA-N 0.000 claims 1
- WNPKHVYUJWDHTA-HEAIWMBWSA-N n-[(3as,4r,6ar)-2-(3,3-diphenylpropyl)-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-2,2-dicyclohexylacetamide Chemical compound C([C@@H]1CC[C@H]([C@@H]1C1)NC(=O)C(C2CCCCC2)C2CCCCC2)N1CCC(C=1C=CC=CC=1)C1=CC=CC=C1 WNPKHVYUJWDHTA-HEAIWMBWSA-N 0.000 claims 1
- NAHLNYDVBZOUFA-BKKFENPESA-N n-[(3as,4r,6ar)-2-[(2r)-2-(dimethylamino)-4-methylpentanoyl]-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-2,2-dicyclohexylacetamide Chemical compound N([C@@H]1CC[C@H]2CN(C[C@H]21)C(=O)[C@H](N(C)C)CC(C)C)C(=O)C(C1CCCCC1)C1CCCCC1 NAHLNYDVBZOUFA-BKKFENPESA-N 0.000 claims 1
- SIYCCBZZNCPXKJ-AQEWBBHDSA-N n-[(3as,4r,6ar)-2-[3,3-bis(4-fluorophenyl)propyl]-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-2,2-dicyclohexylacetamide Chemical compound C1=CC(F)=CC=C1C(C=1C=CC(F)=CC=1)CCN1C[C@H]2[C@H](NC(=O)C(C3CCCCC3)C3CCCCC3)CC[C@H]2C1 SIYCCBZZNCPXKJ-AQEWBBHDSA-N 0.000 claims 1
- FLWIQOZBJZNRSS-KGJXQKDRSA-N n-[(3as,4r,6ar)-2-[4,4-bis(4-fluorophenyl)butyl]-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-2,2-dicyclohexylacetamide Chemical compound C1=CC(F)=CC=C1C(C=1C=CC(F)=CC=1)CCCN1C[C@H]2[C@H](NC(=O)C(C3CCCCC3)C3CCCCC3)CC[C@H]2C1 FLWIQOZBJZNRSS-KGJXQKDRSA-N 0.000 claims 1
- BOPBELRGQUQFBO-PCMUHZCQSA-N n-[(3as,4r,6ar)-2-[6,6-bis(4-fluorophenyl)hexyl]-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-2,2-dicyclohexylacetamide Chemical compound C1=CC(F)=CC=C1C(C=1C=CC(F)=CC=1)CCCCCN1C[C@H]2[C@H](NC(=O)C(C3CCCCC3)C3CCCCC3)CC[C@H]2C1 BOPBELRGQUQFBO-PCMUHZCQSA-N 0.000 claims 1
- OEAFIWPDHPMYFU-HDYLNDSGSA-N n-[(3as,4r,6ar)-2-[[3,5-bis(trifluoromethyl)phenyl]methyl]-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-2,2-dicyclohexylacetamide Chemical compound FC(F)(F)C1=CC(C(F)(F)F)=CC(CN2C[C@H]3[C@H](NC(=O)C(C4CCCCC4)C4CCCCC4)CC[C@H]3C2)=C1 OEAFIWPDHPMYFU-HDYLNDSGSA-N 0.000 claims 1
- YOQYMIKESLMNIW-VHKYSDTDSA-N n-[(3as,4r,6ar)-2-[[3,5-bis(trifluoromethyl)phenyl]methyl]-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-3-(trifluoromethyl)benzenesulfonamide Chemical compound FC(F)(F)C1=CC=CC(S(=O)(=O)N[C@H]2[C@@H]3CN(CC=4C=C(C=C(C=4)C(F)(F)F)C(F)(F)F)C[C@@H]3CC2)=C1 YOQYMIKESLMNIW-VHKYSDTDSA-N 0.000 claims 1
- MIGSRRQGCYFALE-OJDZSJEKSA-N n-[(3as,4r,6ar)-2-benzhydryl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-2,2-dicyclohexylacetamide Chemical compound C([C@@H]1CC[C@H]([C@@H]1C1)NC(=O)C(C2CCCCC2)C2CCCCC2)N1C(C=1C=CC=CC=1)C1=CC=CC=C1 MIGSRRQGCYFALE-OJDZSJEKSA-N 0.000 claims 1
- NWOTVJCUJHEELF-ICDZXHCJSA-N n-[(3as,4r,6ar)-2-benzyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-1-phenylcyclohexane-1-carboxamide Chemical compound C([C@@H]1CC[C@H]([C@@H]1C1)NC(=O)C2(CCCCC2)C=2C=CC=CC=2)N1CC1=CC=CC=C1 NWOTVJCUJHEELF-ICDZXHCJSA-N 0.000 claims 1
- MASLRAWNNPKERH-KSEOMHKRSA-N n-[(3as,4r,6ar)-2-benzyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-1-phenylcyclopropane-1-carboxamide Chemical compound C([C@@H]1CC[C@H]([C@@H]1C1)NC(=O)C2(CC2)C=2C=CC=CC=2)N1CC1=CC=CC=C1 MASLRAWNNPKERH-KSEOMHKRSA-N 0.000 claims 1
- USIBBSAAJMNUPN-JIMJEQGWSA-N n-[(3as,4r,6ar)-2-benzyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-2,2-dicyclohexylacetamide Chemical compound C([C@@H]1CC[C@H]([C@@H]1C1)NC(=O)C(C2CCCCC2)C2CCCCC2)N1CC1=CC=CC=C1 USIBBSAAJMNUPN-JIMJEQGWSA-N 0.000 claims 1
- KQQJEVURYCVLGV-LUOQTNFKSA-N n-[(3as,4r,6ar)-2-benzyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-2,3-diphenylpropanamide Chemical compound C([C@@H]1CC[C@H]([C@@H]1C1)NC(=O)C(CC=2C=CC=CC=2)C=2C=CC=CC=2)N1CC1=CC=CC=C1 KQQJEVURYCVLGV-LUOQTNFKSA-N 0.000 claims 1
- JYMDHABUCGOMGF-VXNFQKBMSA-N n-[(3as,4r,6ar)-2-benzyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-2-benzyl-3,3-dimethylbutanamide Chemical compound N([C@H]1[C@@H]2CN(CC=3C=CC=CC=3)C[C@@H]2CC1)C(=O)C(C(C)(C)C)CC1=CC=CC=C1 JYMDHABUCGOMGF-VXNFQKBMSA-N 0.000 claims 1
- BDECLCVAQQPYIA-QWXVGGSQSA-N n-[(3as,4r,6ar)-2-benzyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-2-cyclopentyl-2-phenylacetamide Chemical compound C([C@@H]1CC[C@H]([C@@H]1C1)NC(=O)C(C2CCCC2)C=2C=CC=CC=2)N1CC1=CC=CC=C1 BDECLCVAQQPYIA-QWXVGGSQSA-N 0.000 claims 1
- ZOWLHDAHUAMRTQ-KSEOMHKRSA-N n-[(3as,4r,6ar)-2-benzyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-2-methyl-2-phenylpropanamide Chemical compound C([C@@H]1CC[C@H]([C@@H]1C1)NC(=O)C(C)(C)C=2C=CC=CC=2)N1CC1=CC=CC=C1 ZOWLHDAHUAMRTQ-KSEOMHKRSA-N 0.000 claims 1
- GGTHRHXEGUHINV-KMWPLCEJSA-N n-[(3as,4r,6ar)-2-benzyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-2-methyl-3-phenylpropanamide Chemical compound N([C@H]1[C@@H]2CN(CC=3C=CC=CC=3)C[C@@H]2CC1)C(=O)C(C)CC1=CC=CC=C1 GGTHRHXEGUHINV-KMWPLCEJSA-N 0.000 claims 1
- HYAPJYSHTFUSQQ-PWRODBHTSA-N n-[(3as,4r,6ar)-2-benzyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-2-propylpentanamide Chemical compound C([C@@H]1CC[C@H]([C@@H]1C1)NC(=O)C(CCC)CCC)N1CC1=CC=CC=C1 HYAPJYSHTFUSQQ-PWRODBHTSA-N 0.000 claims 1
- ZHCVAQPWDAYWNI-DVZSQSHLSA-N n-[(3as,4r,6ar)-2-benzyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-3,3-dimethyl-2-phenylbutanamide Chemical compound C([C@@H]1CC[C@H]([C@@H]1C1)NC(=O)C(C(C)(C)C)C=2C=CC=CC=2)N1CC1=CC=CC=C1 ZHCVAQPWDAYWNI-DVZSQSHLSA-N 0.000 claims 1
- HEVYJRZHYSRHDM-DVZSQSHLSA-N n-[(3as,4r,6ar)-2-benzyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-3-methyl-2-phenylbutanamide Chemical compound C([C@@H]1CC[C@H]([C@@H]1C1)NC(=O)C(C(C)C)C=2C=CC=CC=2)N1CC1=CC=CC=C1 HEVYJRZHYSRHDM-DVZSQSHLSA-N 0.000 claims 1
- PDFATPKTQIBOSI-XUVXKRRUSA-N n-[(3as,4r,6ar)-2-benzyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-3-methyl-2-propan-2-ylbutanamide Chemical compound C([C@@H]1CC[C@H]([C@@H]1C1)NC(=O)C(C(C)C)C(C)C)N1CC1=CC=CC=C1 PDFATPKTQIBOSI-XUVXKRRUSA-N 0.000 claims 1
- IHQZJMDOKJOKIE-RCCFBDPRSA-N n-[(3as,4r,6ar)-2-benzyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-3-methylbutanamide Chemical compound C([C@@H]1CC[C@H]([C@@H]1C1)NC(=O)CC(C)C)N1CC1=CC=CC=C1 IHQZJMDOKJOKIE-RCCFBDPRSA-N 0.000 claims 1
- DTRZRLPYXFUTKP-PWRODBHTSA-N n-[(3as,4r,6ar)-2-benzyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]cycloheptanecarboxamide Chemical compound C([C@@H]1CC[C@H]([C@@H]1C1)NC(=O)C2CCCCCC2)N1CC1=CC=CC=C1 DTRZRLPYXFUTKP-PWRODBHTSA-N 0.000 claims 1
- LCHOSRIKTHYCQA-OTWHNJEPSA-N n-[(3as,4s,6ar)-1,2,3,3a,4,5,6,6a-octahydrocyclopenta[c]pyrrol-4-yl]-2,2-dicyclohexylacetamide Chemical compound N([C@@H]1[C@@H]2CNC[C@@H]2CC1)C(=O)C(C1CCCCC1)C1CCCCC1 LCHOSRIKTHYCQA-OTWHNJEPSA-N 0.000 claims 1
- IQMSVLGPAUPKDT-XKQJLSEDSA-N n-[(3as,4s,6ar)-2-(4-hydroxybutyl)-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-3-(trifluoromethyl)benzenesulfonamide Chemical compound N([C@H]1CC[C@H]2CN(C[C@H]21)CCCCO)S(=O)(=O)C1=CC=CC(C(F)(F)F)=C1 IQMSVLGPAUPKDT-XKQJLSEDSA-N 0.000 claims 1
- SIYCCBZZNCPXKJ-OZAKIQRQSA-N n-[(3as,4s,6ar)-2-[3,3-bis(4-fluorophenyl)propyl]-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-2,2-dicyclohexylacetamide Chemical compound C1=CC(F)=CC=C1C(C=1C=CC(F)=CC=1)CCN1C[C@H]2[C@@H](NC(=O)C(C3CCCCC3)C3CCCCC3)CC[C@H]2C1 SIYCCBZZNCPXKJ-OZAKIQRQSA-N 0.000 claims 1
- GOHBNAADBBNRJH-ITHJLQSDSA-N n-[(3as,4s,6ar)-2-[3-(3-chlorophenyl)propyl]-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-2,2-dicyclohexylacetamide Chemical compound ClC1=CC=CC(CCCN2C[C@H]3[C@@H](NC(=O)C(C4CCCCC4)C4CCCCC4)CC[C@H]3C2)=C1 GOHBNAADBBNRJH-ITHJLQSDSA-N 0.000 claims 1
- SQJSDQPQHGPOKD-GPUOULLFSA-N n-[(3as,4s,6ar)-2-[3-(trifluoromethyl)phenyl]sulfonyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-2,2-dicyclohexylacetamide Chemical compound FC(F)(F)C1=CC=CC(S(=O)(=O)N2C[C@H]3[C@@H](NC(=O)C(C4CCCCC4)C4CCCCC4)CC[C@H]3C2)=C1 SQJSDQPQHGPOKD-GPUOULLFSA-N 0.000 claims 1
- BOPBELRGQUQFBO-ZTTBVOJYSA-N n-[(3as,4s,6ar)-2-[6,6-bis(4-fluorophenyl)hexyl]-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-2,2-dicyclohexylacetamide Chemical compound C1=CC(F)=CC=C1C(C=1C=CC(F)=CC=1)CCCCCN1C[C@H]2[C@@H](NC(=O)C(C3CCCCC3)C3CCCCC3)CC[C@H]2C1 BOPBELRGQUQFBO-ZTTBVOJYSA-N 0.000 claims 1
- OEAFIWPDHPMYFU-DFCKQENNSA-N n-[(3as,4s,6ar)-2-[[3,5-bis(trifluoromethyl)phenyl]methyl]-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-2,2-dicyclohexylacetamide Chemical compound FC(F)(F)C1=CC(C(F)(F)F)=CC(CN2C[C@H]3[C@@H](NC(=O)C(C4CCCCC4)C4CCCCC4)CC[C@H]3C2)=C1 OEAFIWPDHPMYFU-DFCKQENNSA-N 0.000 claims 1
- FJAOHSBTUVUJTC-DMDYGQEQSA-N n-[(3as,4s,6ar)-2-[[3-(trifluoromethyl)phenyl]methyl]-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-2,2-dicyclohexylacetamide Chemical compound FC(F)(F)C1=CC=CC(CN2C[C@H]3[C@@H](NC(=O)C(C4CCCCC4)C4CCCCC4)CC[C@H]3C2)=C1 FJAOHSBTUVUJTC-DMDYGQEQSA-N 0.000 claims 1
- MIGSRRQGCYFALE-YPKYBTACSA-N n-[(3as,4s,6ar)-2-benzhydryl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-2,2-dicyclohexylacetamide Chemical compound C([C@@H]1CC[C@@H]([C@@H]1C1)NC(=O)C(C2CCCCC2)C2CCCCC2)N1C(C=1C=CC=CC=1)C1=CC=CC=C1 MIGSRRQGCYFALE-YPKYBTACSA-N 0.000 claims 1
- USIBBSAAJMNUPN-NXCFDTQHSA-N n-[(3as,4s,6ar)-2-benzyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-2,2-dicyclohexylacetamide Chemical compound C([C@@H]1CC[C@@H]([C@@H]1C1)NC(=O)C(C2CCCCC2)C2CCCCC2)N1CC1=CC=CC=C1 USIBBSAAJMNUPN-NXCFDTQHSA-N 0.000 claims 1
- HEVYJRZHYSRHDM-VDXGAUASSA-N n-[(3as,4s,6ar)-2-benzyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]-3-methyl-2-phenylbutanamide Chemical compound C([C@@H]1CC[C@@H]([C@@H]1C1)NC(=O)C(C(C)C)C=2C=CC=CC=2)N1CC1=CC=CC=C1 HEVYJRZHYSRHDM-VDXGAUASSA-N 0.000 claims 1
- 125000001624 naphthyl group Chemical group 0.000 claims 1
- 208000004296 neuralgia Diseases 0.000 claims 1
- 208000021722 neuropathic pain Diseases 0.000 claims 1
- 201000001119 neuropathy Diseases 0.000 claims 1
- 230000007823 neuropathy Effects 0.000 claims 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 1
- 208000020629 overactive bladder Diseases 0.000 claims 1
- 239000001301 oxygen Substances 0.000 claims 1
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims 1
- 208000033808 peripheral neuropathy Diseases 0.000 claims 1
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 claims 1
- 201000007094 prostatitis Diseases 0.000 claims 1
- 230000001107 psychogenic effect Effects 0.000 claims 1
- 201000000980 schizophrenia Diseases 0.000 claims 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- 231100000872 sexual dysfunction Toxicity 0.000 claims 1
- 208000017520 skin disease Diseases 0.000 claims 1
- 238000006467 substitution reaction Methods 0.000 claims 1
- 125000004434 sulfur atom Chemical group 0.000 claims 1
- 125000006318 tert-butyl amino group Chemical group [H]N(*)C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
- HODGRZURVLFVKM-UHFFFAOYSA-N tert-butyl n-(1,2,3,3a,4,5,6,6a-octahydrocyclopenta[c]pyrrol-4-yl)carbamate Chemical compound C1NCC2C(NC(=O)OC(C)(C)C)CCC21 HODGRZURVLFVKM-UHFFFAOYSA-N 0.000 claims 1
- QMQGMWPJTZZKGJ-UHFFFAOYSA-N tert-butyl n-(2-benzyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl)carbamate Chemical compound C1C2C(NC(=O)OC(C)(C)C)CCC2CN1CC1=CC=CC=C1 QMQGMWPJTZZKGJ-UHFFFAOYSA-N 0.000 claims 1
- AKDVLIPTHUYCSM-MBDNFAEBSA-N tert-butyl n-[(2s)-1-[[(3ar,4r,6as)-2-benzyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]amino]-1-oxopentan-2-yl]-n-methylcarbamate Chemical compound C([C@H]1CC[C@H]([C@H]1C1)NC(=O)[C@@H](N(C)C(=O)OC(C)(C)C)CCC)N1CC1=CC=CC=C1 AKDVLIPTHUYCSM-MBDNFAEBSA-N 0.000 claims 1
- YTJMFBRMPBAOHM-ACESQOTJSA-N tert-butyl n-[(2s)-1-[[(3ar,4r,6as)-2-benzyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]amino]-4-methyl-1-oxopentan-2-yl]-n-methylcarbamate Chemical compound C([C@H]1CC[C@H]([C@H]1C1)NC(=O)[C@@H](N(C)C(=O)OC(C)(C)C)CC(C)C)N1CC1=CC=CC=C1 YTJMFBRMPBAOHM-ACESQOTJSA-N 0.000 claims 1
- USCPUBBBIMFXLS-BVBHFADKSA-N tert-butyl n-[(2s)-1-[[(3ar,4s,6as)-2-(2-methylsulfonylpyrimidin-5-yl)-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]amino]-4,4-dimethyl-1-oxopentan-2-yl]carbamate Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)NC(=O)[C@@H](NC(=O)OC(C)(C)C)CC(C)(C)C)N1C1=CN=C(S(C)(=O)=O)N=C1 USCPUBBBIMFXLS-BVBHFADKSA-N 0.000 claims 1
- VAFASEKTKMPICU-OWSLCNJRSA-N tert-butyl n-[(2s)-1-[[(3ar,4s,6as)-2-[6-(trifluoromethyl)pyridin-2-yl]-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]amino]-4,4-dimethyl-1-oxopentan-2-yl]carbamate Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)NC(=O)[C@@H](NC(=O)OC(C)(C)C)CC(C)(C)C)N1C1=CC=CC(C(F)(F)F)=N1 VAFASEKTKMPICU-OWSLCNJRSA-N 0.000 claims 1
- RMERRCPZSUBJTH-IVAOSVALSA-N tert-butyl n-[(2s)-1-[[(3ar,4s,6as)-2-benzyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]amino]-3,3-dimethyl-1-oxobutan-2-yl]carbamate Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)NC(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)N1CC1=CC=CC=C1 RMERRCPZSUBJTH-IVAOSVALSA-N 0.000 claims 1
- LYTUWBKIQASVQM-MLNNCEHLSA-N tert-butyl n-[(2s)-1-[[(3ar,4s,6as)-2-benzyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]amino]-4,4-dimethyl-1-oxopentan-2-yl]carbamate Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)NC(=O)[C@@H](NC(=O)OC(C)(C)C)CC(C)(C)C)N1CC1=CC=CC=C1 LYTUWBKIQASVQM-MLNNCEHLSA-N 0.000 claims 1
- YTJMFBRMPBAOHM-LDVJMBRRSA-N tert-butyl n-[(2s)-1-[[(3ar,4s,6as)-2-benzyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]amino]-4-methyl-1-oxopentan-2-yl]-n-methylcarbamate Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)NC(=O)[C@@H](N(C)C(=O)OC(C)(C)C)CC(C)C)N1CC1=CC=CC=C1 YTJMFBRMPBAOHM-LDVJMBRRSA-N 0.000 claims 1
- JKRXLJXIYQGLJN-MLNNCEHLSA-N tert-butyl n-[(2s)-1-[[(3ar,4s,6as)-2-benzyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamate Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)NC(=O)[C@@H](NC(=O)OC(C)(C)C)CC(C)C)N1CC1=CC=CC=C1 JKRXLJXIYQGLJN-MLNNCEHLSA-N 0.000 claims 1
- AKDVLIPTHUYCSM-CBPXPLCBSA-N tert-butyl n-[(2s)-1-[[(3as,4r,6ar)-2-benzyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]amino]-1-oxopentan-2-yl]-n-methylcarbamate Chemical compound C([C@@H]1CC[C@H]([C@@H]1C1)NC(=O)[C@@H](N(C)C(=O)OC(C)(C)C)CCC)N1CC1=CC=CC=C1 AKDVLIPTHUYCSM-CBPXPLCBSA-N 0.000 claims 1
- AKDVLIPTHUYCSM-LRSLUSHPSA-N tert-butyl n-[(2s)-1-[[(3as,4s,6ar)-2-benzyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]amino]-1-oxopentan-2-yl]-n-methylcarbamate Chemical compound C([C@@H]1CC[C@@H]([C@@H]1C1)NC(=O)[C@@H](N(C)C(=O)OC(C)(C)C)CCC)N1CC1=CC=CC=C1 AKDVLIPTHUYCSM-LRSLUSHPSA-N 0.000 claims 1
- YTJMFBRMPBAOHM-BJESRGMDSA-N tert-butyl n-[(2s)-1-[[(3as,4s,6ar)-2-benzyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]amino]-4-methyl-1-oxopentan-2-yl]-n-methylcarbamate Chemical compound C([C@@H]1CC[C@@H]([C@@H]1C1)NC(=O)[C@@H](N(C)C(=O)OC(C)(C)C)CC(C)C)N1CC1=CC=CC=C1 YTJMFBRMPBAOHM-BJESRGMDSA-N 0.000 claims 1
- NQRYJNQNLNOLGT-UHFFFAOYSA-N tetrahydropyridine hydrochloride Natural products C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims 1
- 208000014001 urinary system disease Diseases 0.000 claims 1
- 208000009935 visceral pain Diseases 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11799508P | 2008-11-26 | 2008-11-26 | |
| US61/117,995 | 2008-11-26 | ||
| PCT/US2009/065847 WO2010062927A2 (en) | 2008-11-26 | 2009-11-25 | Novel substituted octahydrocyclopenta(c)pyrrol-4-amines as calcium channel blockers |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012509940A JP2012509940A (ja) | 2012-04-26 |
| JP2012509940A5 true JP2012509940A5 (enExample) | 2013-01-17 |
Family
ID=42124348
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011538682A Pending JP2012509940A (ja) | 2008-11-26 | 2009-11-25 | カルシウムチャンネル遮断薬としての置換されたオクタヒドロシクロペンタ［ｃ］ピロール−４−アミン類 |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US8129417B2 (enExample) |
| EP (1) | EP2367790A2 (enExample) |
| JP (1) | JP2012509940A (enExample) |
| KR (1) | KR20110091784A (enExample) |
| CN (1) | CN102292319A (enExample) |
| AR (1) | AR074226A1 (enExample) |
| AU (1) | AU2009319796A1 (enExample) |
| BR (1) | BRPI0921184A2 (enExample) |
| CA (1) | CA2742350A1 (enExample) |
| CL (1) | CL2011001176A1 (enExample) |
| CO (1) | CO6382118A2 (enExample) |
| CR (1) | CR20110304A (enExample) |
| EC (1) | ECSP11011160A (enExample) |
| IL (1) | IL212484A0 (enExample) |
| MX (1) | MX2011005537A (enExample) |
| NZ (1) | NZ592507A (enExample) |
| PA (1) | PA8850301A1 (enExample) |
| PE (1) | PE20110833A1 (enExample) |
| RU (1) | RU2011126215A (enExample) |
| TW (1) | TW201028378A (enExample) |
| UY (1) | UY32261A (enExample) |
| WO (1) | WO2010062927A2 (enExample) |
| ZA (1) | ZA201103538B (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2009319796A1 (en) | 2008-11-26 | 2010-06-03 | Abbvie Inc. | Substituted octahydrocyclopnta (c) pyrrol-4 -amines as calcium channel blockers |
| US8211933B2 (en) * | 2008-12-12 | 2012-07-03 | Vanderbilt University | 3.3.0 bicyclic GlyT1 inhibitors and methods of making and using same |
| US8815869B2 (en) | 2010-03-18 | 2014-08-26 | Abbvie Inc. | Lactam acetamides as calcium channel blockers |
| US8796470B2 (en) | 2010-05-25 | 2014-08-05 | Abbvie Inc. | Substituted octahydrocyclopenta[c]pyrroles as calcium channel modulators |
| WO2011149995A1 (en) * | 2010-05-25 | 2011-12-01 | Abbott Laboratories | Novel substituted octahydrocyclopenta [c]pyrrol-4-amines as calcium channel blockers |
| FR2976285B1 (fr) * | 2011-06-08 | 2013-05-24 | Servier Lab | Procede de synthese et forme cristalline du chlorhydrate de 4-{3-[cis-hexahydrocypenta[c]pyrrol-2(1h)-yl]propoxy}benzamide ainsi que les compositions pharmaceutiques qui la contiennent |
| WO2013049164A1 (en) | 2011-09-29 | 2013-04-04 | Abbvie Inc. | SUBSTITUTED OCTAHYDROPYRROLO[1,2-a]PYRAZINES AS CALCIUM CHANNEL BLOCKERS |
| WO2013049174A1 (en) | 2011-09-29 | 2013-04-04 | Abbvie Inc. | Substituted octahydropyrrolo[1,2-a]pyrazine sulfonamides as calcium channel blockers |
| CN105008361A (zh) | 2012-12-12 | 2015-10-28 | 艾伯维公司 | 作为钙通道阻滞剂用于治疗疼痛的的二氮杂*衍生物 |
| CN106565674B (zh) * | 2015-10-13 | 2021-02-05 | 四川海思科制药有限公司 | 一种八氢环戊烷并[c]吡咯衍生物及其制备方法和在医药上的用途 |
| TWI851542B (zh) * | 2017-09-11 | 2024-08-11 | 美商克魯松藥物公司 | Ｓｈｐ２之八氫環戊烷并[c]吡咯別構抑制劑 |
| KR102656571B1 (ko) | 2018-03-05 | 2024-04-11 | 아르커스 바이오사이언시즈 인코포레이티드 | 아르기나아제 억제제 |
| CA3214469A1 (en) * | 2021-04-01 | 2022-10-06 | Ono Pharmaceutical Co., Ltd. | Abhd6 antagonist |
| TW202421635A (zh) | 2022-09-30 | 2024-06-01 | 日商小野藥品工業股份有限公司 | Abhd6拮抗劑 |
| KR20240046089A (ko) | 2022-09-30 | 2024-04-08 | 오노 야꾸힝 고교 가부시키가이샤 | Abhd6 길항제를 함유하는 약학 조성물 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0278659A (ja) | 1988-09-12 | 1990-03-19 | Shionogi & Co Ltd | アザビシクロアルカン類化合物 |
| ATE269848T1 (de) * | 1999-04-07 | 2004-07-15 | Univ Virginia | Calciumkanalblocker als antikrebsmittel |
| US8163769B2 (en) * | 2002-03-12 | 2012-04-24 | Abbott Laboratories | Antibacterial compounds |
| US7223754B2 (en) * | 2003-03-10 | 2007-05-29 | Dynogen Pharmaceuticals, Inc. | Thiazolidinone, oxazolidinone, and imidazolone derivatives for treating lower urinary tract and related disorders |
| EP1631570A1 (en) * | 2003-03-12 | 2006-03-08 | Abbott Laboratories | Naphthyridine derivatives as antibacterial agents |
| US7230022B2 (en) * | 2004-02-19 | 2007-06-12 | Bristol-Myers Squibb Company | Substituted fused bicyclic amines as modulators of chemokine receptor activity |
| US7381738B2 (en) * | 2004-02-19 | 2008-06-03 | Bristol-Myers Squibb Company | Substituted bicycloalkylamine derivatives as modulators of chemokine receptor activity |
| JP2008507543A (ja) * | 2004-07-22 | 2008-03-13 | グラクソ グループ リミテッド | 抗細菌剤 |
| DE102004039789A1 (de) * | 2004-08-16 | 2006-03-02 | Sanofi-Aventis Deutschland Gmbh | Arylsubstituierte polycyclische Amine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| JP2008536927A (ja) * | 2005-04-19 | 2008-09-11 | メルク エンド カムパニー インコーポレーテッド | Ｎ−アルキル−アザシクロアルキルｎｍｄａ／ｎｒ２ｂ拮抗物質 |
| WO2010039947A1 (en) | 2008-10-02 | 2010-04-08 | Abbott Laboratories | Novel compounds as calcium channel blockers |
| AU2009319796A1 (en) | 2008-11-26 | 2010-06-03 | Abbvie Inc. | Substituted octahydrocyclopnta (c) pyrrol-4 -amines as calcium channel blockers |
| US8211933B2 (en) * | 2008-12-12 | 2012-07-03 | Vanderbilt University | 3.3.0 bicyclic GlyT1 inhibitors and methods of making and using same |
-
2009
- 2009-11-25 AU AU2009319796A patent/AU2009319796A1/en not_active Abandoned
- 2009-11-25 TW TW098140141A patent/TW201028378A/zh unknown
- 2009-11-25 PA PA20098850301A patent/PA8850301A1/es unknown
- 2009-11-25 EP EP09764953A patent/EP2367790A2/en not_active Withdrawn
- 2009-11-25 KR KR1020117014731A patent/KR20110091784A/ko not_active Withdrawn
- 2009-11-25 US US12/625,754 patent/US8129417B2/en not_active Expired - Fee Related
- 2009-11-25 NZ NZ592507A patent/NZ592507A/xx not_active IP Right Cessation
- 2009-11-25 RU RU2011126215/04A patent/RU2011126215A/ru not_active Application Discontinuation
- 2009-11-25 CN CN2009801553748A patent/CN102292319A/zh active Pending
- 2009-11-25 UY UY0001032261A patent/UY32261A/es not_active Application Discontinuation
- 2009-11-25 MX MX2011005537A patent/MX2011005537A/es unknown
- 2009-11-25 CA CA2742350A patent/CA2742350A1/en not_active Abandoned
- 2009-11-25 AR ARP090104557A patent/AR074226A1/es not_active Application Discontinuation
- 2009-11-25 JP JP2011538682A patent/JP2012509940A/ja active Pending
- 2009-11-25 PE PE2011001093A patent/PE20110833A1/es not_active Application Discontinuation
- 2009-11-25 BR BRPI0921184A patent/BRPI0921184A2/pt not_active IP Right Cessation
- 2009-11-25 WO PCT/US2009/065847 patent/WO2010062927A2/en not_active Ceased
-
2011
- 2011-04-26 IL IL212484A patent/IL212484A0/en unknown
- 2011-05-13 ZA ZA2011/03538A patent/ZA201103538B/en unknown
- 2011-05-19 CL CL2011001176A patent/CL2011001176A1/es unknown
- 2011-05-27 CO CO11065858A patent/CO6382118A2/es not_active Application Discontinuation
- 2011-06-06 CR CR20110304A patent/CR20110304A/es not_active Application Discontinuation
- 2011-06-24 EC EC2011011160A patent/ECSP11011160A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012509940A5 (enExample) | ||
| RU2011126215A (ru) | НОВЫЕ ЗАМЕЩЕННЫЕ ОКТАГИДРОЦИКЛОПЕНТА[c]ПИРРОЛ-4-АМИНЫ В КАЧЕСТВЕ БЛОКАТОРОВ КАЛЬЦИЕВЫХ КАНАЛОВ | |
| JP2004508304A5 (enExample) | ||
| JP2016510032A5 (enExample) | ||
| CN1315806C (zh) | 取代的2－氨基－环烷烃甲酰胺和它们作为半胱氨酸蛋白酶抑制剂的用途 | |
| CN102482212B (zh) | 羧酰胺化合物及它们作为钙蛋白酶抑制剂的用途 | |
| JP2010053153A (ja) | Ｃｂ１受容体拮抗剤の経口用医薬組成物 | |
| CN1826325A (zh) | 作为p2x7离子通道阻滞剂的4,5－二氢－咪唑 | |
| RU2005114486A (ru) | Производные сульфониламиноуксусной кислоты и их применение в качестве антагонистов рецепторов орексина | |
| JP4519861B2 (ja) | 新規なアザ二環式誘導体、その製造方法、およびそれを含む医薬組成物 | |
| JP2020523388A5 (enExample) | ||
| JP2012515209A5 (enExample) | ||
| RU2009118254A (ru) | Фенилацетамиды в качестве ингибиторов протеинкиназ | |
| JP2010505881A5 (enExample) | ||
| RU2011134052A (ru) | Новые бензолсульфонамиды в качестве блокаторов кальциевых каналов | |
| CN105263924B (zh) | Cxcr7受体调节剂 | |
| JP2012507525A5 (enExample) | ||
| TW201712004A (zh) | 吡唑衍生物或其藥理學上容許之鹽 | |
| JPWO1994002472A1 (ja) | チアゾリン誘導体 | |
| JP3949708B2 (ja) | ケモカイン受容体介在疾患を治療するためのポリアミン化合物 | |
| CN101981006A (zh) | 环状吲哚-3-甲酰胺、其制备和其作为药物的用途 | |
| CN1260798A (zh) | 具有5－羟色胺－2受体拮抗作用和α1－阻断作用的吡咯噻嗪和吡咯硫杂吖庚因化合物 | |
| CN1268938A (zh) | 氨基环烷烃化合物 | |
| AU2012268119B2 (en) | [1,2,4]thiadiazine 1,1-dioxide compounds for lowering serum uric acid | |
| CA2577667A1 (en) | 3-substituted-5- and 6-aminoalkyl indole-2-carboxylic acid amides and related analogs as inhibitors of casein kinase ie |